4//SEC Filing
Viswanadhan Krishnan 4
Accession 0001439222-25-000027
CIK 0001439222other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:18 PM ET
Size
7.9 KB
Accession
0001439222-25-000027
Insider Transaction Report
Form 4
Viswanadhan Krishnan
Chief Corp Dev & Strategy
Transactions
- Award
Restricted stock units
2025-03-05+24,300→ 24,300 total→ Common stock (24,300 underlying) - Award
Stock options (right to buy)
2025-03-05+55,374→ 55,374 totalExercise: $33.95Exp: 2035-03-05→ Common stock (55,374 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on March 5, 2025. Beginning on March 5, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
- [F3]This option was granted on March 5, 2025. The shares underlying this option vest as to 25% of the underlying shares on March 5, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001999913
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:18 PM ET
- Size
- 7.9 KB